ResMed Inc. (ASX:RMD)
Australia · Delayed Price · Currency is AUD 40.68
-0.57 (-1.38%)
Sep 15, 2025, 4:11 PM AEST
ResMed Market Cap
ResMed has a market cap or net worth of 59.41 billion as of September 15, 2025. Its market cap has increased by 13.14% in one year.
Market Cap
59.41B
Enterprise Value
58.87B
Revenue
7.85B
Ranking
n/a
PE Ratio
27.80
Stock Price
40.68
Market Cap Chart
Since June 2, 1995, ResMed's market cap has increased from 53.86M to 59.41B, an increase of 110,191.78%. That is a compound annual growth rate of 26.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 12, 2025 | 59.41B | 9.47% |
| Dec 31, 2024 | 54.27B | 46.20% |
| Dec 29, 2023 | 37.12B | -17.49% |
| Dec 30, 2022 | 44.98B | -14.11% |
| Dec 31, 2021 | 52.37B | 31.17% |
| Dec 31, 2020 | 39.93B | 25.89% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 100.64B |
| Pro Medicus | 31.19B |
| Cochlear | 19.61B |
| Sonic Healthcare | 11.19B |
| Ramsay Health Care | 7.72B |
| Ansell | 4.89B |
| Telix Pharmaceuticals | 4.63B |
| Mesoblast | 2.83B |